Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
31 hedge funds and large institutions have $6.4M invested in Pernix Therapeutics Holdings, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.
67% more capital invested
Capital invested by funds: $3.83M → $6.4M (+$2.57M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
9% less funds holding
Funds holding: 34 → 31 (-3)
12% less call options, than puts
Call options by funds: $894K | Put options by funds: $1.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$574K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$285K |
| 3 |
Renaissance Technologies
New York
|
+$150K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$139K |
| 5 |
SC
Searle & Co
Greenwich,
Connecticut
|
+$54.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
-$521K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$271K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$80K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$79K |
| 5 |
D.E. Shaw & Co
New York
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$79K | -40,863 | Closed |
|
|
27
D.E. Shaw & Co
New York
| – | -$37K | -18,914 | Closed |
|
|
AG
28
Algert Global
San Francisco,
California
| – | -$24K | -12,570 | Closed |
|
|
AIM
29
Acrospire Investment Management
Chicago,
Illinois
| – | -$21K | -11,026 | Closed |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$31.4K | -10,000 | -99% |
|
|
PAM
31
Panagora Asset Management
Boston,
Massachusetts
| – | -$2K | -847 | Closed |
|
32
JP Morgan Chase
New York
| – | +$314 | +100 | New |
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$628 | +200 | +20,000% |
|
PTX Hedge Fund Activity: Q1 2017 in Review
31 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q1 2017, worth a combined $6.4M — up 67% from $3.83M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PTX positions and 8 closed out — a net gain of 1 holder — while 7 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $574K. The largest seller was Globeflex Capital, exiting entirely with an estimated $521K sold.
- 31 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q1 2017, down from 34 in Q4 2016.
- Funds reported $6.4M of Pernix Therapeutics Holdings, Inc. stock for Q1 2017, up 67% quarter-over-quarter.
- 9 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q1 2017 and 8 closed out, a net change of +1 holder.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q1 2017 was BlackRock, an estimated $574K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q1 2017 was Globeflex Capital, an estimated $521K sold.
Based on aggregated 13F filings for Q1 2017.